JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 50 filers reported holding JUNIPER PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $456,000 | +31.4% | 52,500 | +53.5% | 0.03% | +22.7% |
Q1 2018 | $347,000 | +114.2% | 34,200 | +2.1% | 0.02% | +144.4% |
Q4 2017 | $162,000 | -22.1% | 33,485 | -26.9% | 0.01% | -18.2% |
Q3 2017 | $208,000 | -31.4% | 45,800 | -23.7% | 0.01% | -42.1% |
Q2 2017 | $303,000 | +41.6% | 60,000 | +33.0% | 0.02% | +35.7% |
Q1 2017 | $214,000 | -24.1% | 45,100 | -10.7% | 0.01% | -39.1% |
Q4 2016 | $282,000 | +5.2% | 50,500 | +4.3% | 0.02% | +4.5% |
Q3 2016 | $268,000 | -11.8% | 48,400 | +11.3% | 0.02% | -21.4% |
Q2 2016 | $304,000 | -13.6% | 43,500 | -18.5% | 0.03% | -22.2% |
Q1 2016 | $352,000 | -25.3% | 53,400 | +16.6% | 0.04% | -40.0% |
Q4 2015 | $471,000 | +2.2% | 45,800 | +16.8% | 0.06% | 0.0% |
Q3 2015 | $461,000 | +145.2% | 39,200 | +86.7% | 0.06% | +130.8% |
Q2 2015 | $188,000 | – | 21,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 481,459 | $5,672,000 | 2.05% |
Krensavage Asset Management, LLC | 279,717 | $3,295,000 | 1.19% |
EAM Investors, LLC | 145,898 | $1,719,000 | 0.27% |
PERRITT CAPITAL MANAGEMENT INC | 93,000 | $1,096,000 | 0.23% |
TFS CAPITAL LLC | 99,823 | $1,176,000 | 0.11% |
Bellevue Asset Management AG | 50,000 | $589,000 | 0.10% |
CADENCE CAPITAL MANAGEMENT LLC | 88,232 | $1,039,000 | 0.07% |
Spark Investment Management LLC | 39,200 | $461,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 100,564 | $1,185,000 | 0.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 35,599 | $419,000 | 0.03% |